New research shows that, despite significant new advancements in treatments for type II diabetes, this has not translated to better health for those patients. In fact, fewer than 1 in 4 Americans with type II diabetes have achieved the American Diabetes Association's recommended care targets ... no better than 15 years ago. Joining me for this episode is Pooyan Kazemian, instructor in medicine at Harvard University Medical School and a research scientist at Massachusetts General Hospital.